BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the recipient of a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 46,393 shares, a growth of 433.3% from the April 30th total of 8,700 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 3,299 shares, the days-to-cover ratio is currently 14.1 days.
BioNxt Solutions Stock Up 6.8%
BNXTF opened at $0.31 on Thursday. The firm has a market capitalization of $37.41 million, a P/E ratio of -7.64 and a beta of 0.69. The stock’s 50 day moving average price is $0.36 and its two-hundred day moving average price is $0.42. BioNxt Solutions has a 12-month low of $0.14 and a 12-month high of $0.80.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.
BioNxt Solutions Company Profile
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Read More
- Five stocks we like better than BioNxt Solutions
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
